Main 23 Genomic sequence variation within enhancers and promoters can have a significant 24 impact on the cellular state and phenotype, as illustrated by many disease-associated 25 SNPs 1 and mutations 2 in the non-coding genome. However, sifting through the millions 26 of candidate variants in a personal genome or cancer genome, to identify only those 27 variants that impact enhancer function, remains a major challenge. Commonly, two 28 approaches are taken to overcome/tackle this problem. The first one is quantitative trait 29 loci (QTL) analysis in which a variant is correlated to a cellular trait across a large number 30 of samples. This strategy is widely used with expression data, as well as chromatin 31 immunoprecipitation and chromatin accessibility data, for detecting QTL associated with 32 gene expression (eQTL), transcription factor binding (bQTL) 3 , histone modifications 33 (hQTL) 4 , or chromatin accessibility (caQTL) 5 respectively. This type of analysis suffers 34 from the requirement of large sample sizes, since the effect sizes of these variants are 35 usually low. The alternative approach is to assess allelic imbalance at a heterozygous 36 site itself by comparing the two alleles of the diploid genome against each other. This 37 allele counting approach is extensively used with RNA-seq data to identify allele-specific 38 expression variants 8 , but is also applicable to other types of functional genomics data 6 . 39 Here, the strategy relies on finding the allelic origin of the signal observed in functional 40 genomics data. The use of a personalized diploid genome prevents potential technical 41 biases and ensures obtaining accurate allelic counts 6, 7 . Importantly, this approach can 42 work even with a single sample, if (phased) high quality variants are available and a 43 personalized diploid genome can be reliably constructed. This is especially true for cancer 44 genomes that often have a large number of differences from the reference genome. 45 46 In this study we investigate how allele-specific changes in chromatin accessibility -as a 47 proxy for transcription factor occupancy -combined with deep learning and motif analysis 48 can be exploited to distinguish functional from non-functional enhancer mutations in 49 phased melanoma genomes (Figure 1a) . We obtained haplotype-resolved whole 50 genome sequence (WGS) data of 10 patient-derived melanoma cultures (MM lines) using 51 linked-reads technology from 10X Genomics. Each sample was sequenced to an average 52 depth of 38X (except MM087 at 68X and MM099 at 133X). We also obtained chromatin 53 accessibility profiles of the same melanoma lines with ATAC-seq 8 (9 samples were 54 profiled with OmniATAC-seq and were obtained from Wouters et al 8 ; while ATAC-seq 55 data for A375 was downloaded from GSE82330 9 ). For combining the personal diploid 56 genomes with ATAC-seq, we used a modified alleleseq pipeline to obtain allele-specific 57 chromatin accessibility variants (ASCAVs) 10 (Figure 1a,b ) (see Materials and Methods). 58 The BaalChIP 11 method then enabled us to correct the observed allelic ratios from ATAC-59 seq reads using the genomic allelic ratios from the whole genome sequence data to 60 correct for copy number variations that are frequently observed in these lines ( Figure S1 ). 61 From a total of 16 million phased variants across 10 genomes (Figure 1c) , 139,420 62 variants overlap with ATAC-seq peaks, from which we identified 20,464 (14.7%) to 63 represent significant ASCAVs across the 10 genomes (ranging from 451 to 7,183 per 64 sample) ( Table S3 ,4). The majority of the ASCAVs are unique to one MM line, and a 65 small proportion shared between multiple samples (1,533 out of 20,464; 7.5%) ( Figure   66 S2). Only two of the shared ASCAVs are called discordantly between the samples 67 (rs61794783 with G>C/T, and rs673002 with G>T/C) which are multiallelic sites 68 (dbSNP150), illustrating the accuracy of the ASCAV pipeline. We also assembled a set 69 of control SNPs, namely heterozygous SNPs within ATAC-seq peaks that show no allelic 70 bias. The genomic distribution of both sets, ASCAVs and control SNPs, is highly similar 71 ( Figure S3 , Table S5 ). Phased whole genome sequencing is applied to 10 melanoma cell lines, and used together with the 75 reference genome to create personalized diploid genomes. Matched ATAC-seq and RNA-seq data is used 76 to detect allelic imbalance in chromatin accessibility (ASCA) or gene expression (ASE). By combining a 77 melanoma-specific deep learning model (DeepMEL), and motif discovery, cis-regulatory variants are 78 predicted. b. Analysis pipeline. c. Sankey diagram of the number of variants that went through our ASCA 79 discovery pipeline. 16 million phased heterozygous variants across 10 melanoma genomes are filtered to 80 retain 139,420 variants that overlap with an ATAC-seq peak, of which 20,464 present allelic imbalance.
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Novel/SNP ratio shows a significant shift in the ASCA variants compared to control variants (OR of 1.8 with 82 FET p-value of <0.01) with an average 5.5% novel variants in ASCA group compared to 2.6 % novel When testing for allele-specific expression (ASE) using matched RNA-seq data on the 99 same MM lines 12 we identified 20,746 distinct ASE variants, associated with 9,787 genes 100 (Table S6 ). One gene, namely MAP2K3 (also known as MEK3), shows ASE in all 10 101 samples; this gene has been previously reported to be expressed in an allele-specific 102 manner in various human and mouse tissues 13, 14 . Globally, there is a significant 103 enrichment of ASCAVs near genes with ASE (p-value 0.005 with Fisher's exact test) with 104 12.8% of ASCAVs being located 2 kb upstream (promoter) or within an intron of an ASE 105 gene (Table S7 ). However, despite this enrichment, using the proximity of ASE alone is 106 not accurate enough to prioritize functional cis-regulatory variants.
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A commonly applied strategy to predict the functional relevance of a putative cis-109 regulatory variant, is to predict its impact on the encompassing enhancer or promoter, 110 namely the creation or destruction of a transcription factor binding site 2,5,15 . However, 111 binding site predictions using position weight matrices (PWM) are notorious for their high 112 false positive rates 16 . To overcome this problem, we propose a motif enrichment strategy 113 to identify PWMs that present significantly more changes than expected by chance, 114 across the entire set of ASCAVs. In addition, more advanced machine-learning models 115 have been used that are trained on enhancers and take flanking sequence information 116 into account, including gapped k-mer SVMs 17 and deep learning models like Basset 18 , 117 Basenji 19 , DanQ 20 , DeepBind 21 , DeepSea 22 , and FactorNet 23 . Such models are available 118 in Kipoi 24 , and can be readily applied to score cis-regulatory variants. However, these 119 generic models are usually trained on large collections of epigenomics data, allowing their 120 employment to "any" cell type. In contrast, we follow a different strategy, specifically (Figure 1f, Figure S8 ). In line with our previous observations, the AP-1 filter 171 is the most frequently altered, followed by the SOX10. The second XAI technique we used 172 is based on DeepExplainer 38 , which assesses how much each nucleotide in the enhancer 173 contributes to its classification (Figure 1h ). This analysis highlights the fact that enhancer 174 mutations that affect chromatin accessibility mainly occur in TF binding sites within the 175 enhancer, and that the most commonly affected motif in MEL enhancers is the SOX10 176 motif. Indeed, presence or absence of a SOX10 motif has the greatest influence on 177 changes in ATAC-seq signal, among the MEL enhancer motifs (Figure 1f, Figure S9) . 178 Nevertheless, a subset of ASCAVs can also be explained by changes in TFAP2 and MITF 179 motifs (Figure S10, Figure S11 ). Interestingly, and in line with our previous observations, 180 SNPs that create a ZEB/SNAI motif result in a decrease in chromatin accessibility, 181 suggesting that these factors promote nucleosome stability at the enhancer, or (Figure 1h) . From this assay we find that ASCAVs overlap with in silico 188 predicted vulnerable nucleotides (Figure S10 and Figure S11) . 189 190 191 Our phased genomes allow linking the allelic imbalance of chromatin accessibility with 192 the allele-specific expression of nearby genes. 12.6% of ASCAVs that can be explained 193 by motif changes are located near (2 kb upstream or intronic) a gene that presents ASE. 194 Therefore, these enhancer mutations may underlie the change in expression of the target 195 gene. To further examine this, we selected three enhancers in MM057 for which the 196 predicted target gene shows ASE. The first two examples, PEPD and MITF, have a 197 predicted gain of an AP-1 motif, as indicated by DeepMEL (Figure 2a,b, Figure S12 ). 198 Luciferase reporter assays conducted in the same cell line using sequences of both 199 haplotypes confirm the potency of these variants to drive enhancer activity, only when the 200 AP-1 site is present (Figure 2a,b) . The third example is an enhancer in the first intron of 201 EVA1C with a predicted SOX10 motif gain by the DeepMEL model. This variant 202 (rs2833812) is identified as a phased heterozygous SNP in four lines (MM031, MM057. 203 MM074, MM087) and results in allele specific accessibility in all cases (Figure S13) . 204 Again, when assessed with luciferase reporter assay (in MM057), only the enhancer 205 sequence that carries the SNP generating the SOX10 motif is able to drive luciferase 206 activity (Figure 2c) . This suggests that enhancer mutations associated with changes in 
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Each row (a,b,c) shows a detected ASCAV with in its locus with an inset of the allele-specific accessibility 224 peak (I); the DeepExplainer plots and in silico mutagenesis of the two haplotypes (II); the DeepMEL score 225 for both haplotypes (III); and the luciferase enhancer-reporter activity for both haplotypes (IV). Personalized genome construction 272 Variant calls (as generated by longranger) and structural variation calls (as generated by 273 Sniffles) were used to construct personalized genomes with Crossstich. This procedure 274 resulted in generation of personalized reference sequences per haplotype in fasta format 275 as well as chain files that link reference genome to personalized genomes. To obtain 276 chain files to link personalized genomes to reference genome, we performed whole 277 genome alignment between personalized genomes and reference genome using Blat. 278 Briefly, we partitioned the reference genome into 3kb pieces per chromosome and 279 mapped to personalized genomes with Blat using the following options: -tileSize=11 - 288 ATAC-seq data was generated using the OmniATAC-seq technique as described 289 previously 40 . Cells were washed, trypsinized, spun down at 1000 RPM for 5 min, medium 290 was removed and the cells were resuspended in 1 mL medium. Cells were counted and 291 experiments were only continued when a viability of above 90% was observed. 50,000 292 cells were pelleted at 500 RCF at 4°C for 5 min, medium was carefully aspirated and the 293 cells were washed and lysed using 50 uL of cold ATAC-Resupension Buffer (RSB) (see 294 Corces et al., 2017 for composition) containing 0.1% NP40, 0.1% Tween-20 and 0.01% 295 digitonin by pipetting up and down three times and incubating the cells on ice for 3 min. 296 1 mL of cold ATAC-RSB containing 0.1% Tween-20 was added and the eppendorf was 297 inverted three times. Nuclei were pelleted at 500 RCF for 10 min at 4°C, the supernatant 314 We aimed at obtaining minimum 15M usable reads per sample, and eventually achieved 315 41M reads on average across 9 sequenced samples (see Methods) (Table S1 ). Paired-316 end reads were mapped to the human genome (hg38) using bowtie2 with --very-sensitive 317 option (v2.2.6). Mapped reads were sorted using SAMtools (v1.8) and duplicates were 318 removed using Picard MarkDuplicates (v1.134). Reads were filtered by removing 319 chromosome M reads and filtering for Q>2 using SAMtools. Usable reads is defined as 320 the number of reads retained after these filtering steps. Paired-end reads were mapped 321 to the sample specific personalized genomes using bowtie2 (v2.2.6). Mapped reads were 322 sorted using SAMtools (v1.8) and duplicates were removed using Picard MarkDuplicates 323 (v1.134). Reads were filtered by removing chromosome M reads and filtering for Q>2 324 using SAMtools. We observed that the number of reads mapping to personalized 325 genomes were slightly higher than the number of reads mapping to the reference genome 326 (hg38), which has been reported previously for ChIP-seq data 6,41 (Table S2) . (ENCSR636HFF). Per sample, we obtained reference mapped peaks, HAP1 mapped 336 peaks and HAP2 mapped peaks. To obtain a consolidated peak set per sample, we 337 followed the strategy described by Corces et al 42 . Briefly, peak scores within each peakset 338 was standardized by dividing peak scores to the sum of all peak scores for that sample. 339 Haplotype 1 and 2 mapped peak sets lifted over to reference genome and consolidated 340 peak set per sample obtained by an iterative filtering strategy: peaks were ranked by their 341 normalized peak score, and any peak that overlapped with the highest scoring peak was 342 filtered out. Next, the second highest scoring peak is processed this way, and the same 343 procedure is repeated until a non-overlapping peak set is obtained. This strategy enabled 344 us to obtain 500bp fixed-width peaks that are not biased towards the reference genome 345 (referred to as consolidated peak sets). Identification of allele-specific events in ATAC-seq data 351 We have built a new allele specific variant detection pipeline using the backbone of 352 alleleSeq pipeline 10 . We used Bowtie2 43 to map ATAC-seq reads to personalized 353 genomes as described above. Next, we marked duplicate reads in each alignment using 354 Picard. Then, we evaluated two alignment files (ie. haplotype 1 mapped and haplotype 2 355 mapped) to identify the most likely origin of each read. Each read was evaluated iteratively 356 using mapping quality (MapQ), CIGAR string and XM tag (which reports the number of 357 mismatches in the alignment) If the read had the same mapQ, same CIGAR string (or the 358 same number of Ms) and same XM tag for both alignments, it was marked as commonly 359 mapping. This step resulted in four bam files: haplotype1.exclusive, haplotype2.exclusive, 360 haplotype1.common and haplotype2.common. 361 After identifying the source of each read, we filtered out duplicate reads. We also filtered 362 out ambiguously mapping reads by evaluating the reads that map equally well to both 363 haplotypes (ie. reads in haplotype1.common and haplotype2.common alignment files) in 364 the reference genome. We lifted these positions over to hg38 coordinates, and discarded 365 reads if it mapped to different locations. Next, we overlapped phased heterozygous 366 variants obtained from whole genome sequence data with consolidated peak set (as 367 described above). The variant positions that overlapped with the peaks were lifted over 368 to haplotype 1 and 2 coordinates, and allele counts were obtained using samtools mpileup 369 command with all four alignment files (allelic counts coming from common alignment files 370 were compared and no major differences were found). Then allelic counts over 371 heterozygous sites were merged, and variants that had at least 6 reads were further Motif enrichment analysis with allele-specific binding events 383 ASCA and control variants per sample were overlapped with consolidated ATAC-seq 384 peaks. Peaks that had multiple variants were filtered out if the allelic bias between variants 385 was inconsistent. Allelic counts were used to determine preferred allele (i.e. allele that 386 has the highest ATAC-seq signal). Peak sequences were extracted from the fasta 387 sequence of the preferred allele (using fastaFromBed command from bedtools 44 ) 388 Reference sequence for each variant was extracted from hg38 using the same command. 389 For each peak, we calculated the CRM score for the preferred allele and the other allele 390 (reference sequence) using a set of 22,000 position weight matrices 27 , and calculated a 391 "delta CRM score" for each peak and for each motif (Figure 1d) . We evaluated the 392 enrichment of CRM delta's in ATAC-seq peaks using one-sided Fishers' exact test with a 393 control set of 82,536 peaks containing non-ASCA variants. We performed enrichment 394 analysis individually (per MM-line) and globally (across all MM-lines) (Figure 1d 
ATAC-seq library preparation

ATAC-seq alignment to the reference and personalized genomes
Scoring enhancers and ASCAVs with DeepMEL
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To score ASCAVs, we perturbed the 500bp ATAC-seq peaks by doing a single nucleotide 421 change according to variants coming from two alleles. We calculated delta prediction 422 score for each of the ASCAVs and the control variants for each of the classes. Then, we 423 evaluated the delta prediction scores for each class (mainly MEL and MES classes) to 424 identify the fraction of explainable ASCAVs using a one-sided Fishers' exact test with a 425 control set of 118,954 non-ASCA variants at 10% FDR.
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Assessing the mostly affected convolutional filters 428 To identify the most affected convolutional filters (128 filters in the convolutional layer of 429 DeepMEL) by ASCAVs, we calculated a "delta activation score" of each convolutional 430 filter for each ASCAV individually by getting the output of the convolutional layer using 431 the enhancer sequence as input, before and after creating a single nucleotide change 432 according to the ASCAV. We evaluated the enrichment of the delta activation scores for 433 each filter using a one-sided Fishers' exact test with a control set of 118,954 non-ASCA 434 variants at 10% FDR.
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European Genome-phenome Archive (EGA; http://www.ebi.ac.uk/ega/). The code for the analysis  470  of  the  WGS  data  and  detection  of  ASCAV  is  deposited  at  471 https://github.com/aertslab/AS_variant_pipeline. The DeepMEL model is available from Kipoi. 472
